By Theresa Schliep ( January 11, 2024, 9:41 PM EST) -- A group of economists and health policy scholars urged a New Jersey federal court Thursday to reject Janssen Pharmaceuticals Inc.'s bid for a win without trial in its challenge to Medicare drug price negotiations, arguing the program makes the drug market more, not less, competitive....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.